HK1209041A1 - A method of weight reduction - Google Patents

A method of weight reduction

Info

Publication number
HK1209041A1
HK1209041A1 HK15109728.3A HK15109728A HK1209041A1 HK 1209041 A1 HK1209041 A1 HK 1209041A1 HK 15109728 A HK15109728 A HK 15109728A HK 1209041 A1 HK1209041 A1 HK 1209041A1
Authority
HK
Hong Kong
Prior art keywords
weight reduction
reduction
weight
Prior art date
Application number
HK15109728.3A
Other languages
English (en)
Chinese (zh)
Inventor
Ken Walder
Guy Krippner
Geoff Nicholson
Original Assignee
Verva Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verva Pharmaceuticals Ltd filed Critical Verva Pharmaceuticals Ltd
Publication of HK1209041A1 publication Critical patent/HK1209041A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15109728.3A 2012-05-24 2015-10-06 A method of weight reduction HK1209041A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261651335P 2012-05-24 2012-05-24
PCT/AU2013/000259 WO2013173858A1 (fr) 2012-05-24 2013-03-15 Procédé de diminution de poids

Publications (1)

Publication Number Publication Date
HK1209041A1 true HK1209041A1 (en) 2016-03-24

Family

ID=49622926

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109728.3A HK1209041A1 (en) 2012-05-24 2015-10-06 A method of weight reduction

Country Status (16)

Country Link
US (2) US20150174108A1 (fr)
EP (1) EP2854806A4 (fr)
JP (1) JP6438389B2 (fr)
KR (1) KR20150023404A (fr)
CN (1) CN104582701B (fr)
AU (1) AU2013202981B2 (fr)
BR (1) BR112014029302A2 (fr)
CA (1) CA2874512A1 (fr)
CO (1) CO7160083A2 (fr)
HK (1) HK1209041A1 (fr)
MX (1) MX2014014316A (fr)
NZ (1) NZ702666A (fr)
RU (1) RU2664442C2 (fr)
SG (1) SG11201407786XA (fr)
WO (1) WO2013173858A1 (fr)
ZA (1) ZA201408703B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089521A1 (fr) 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Sensibilisateurs a l'iinsuline et procédés de traitement
WO2013173859A1 (fr) * 2012-05-24 2013-11-28 Verva Pharmaceuticals Ltd Procédé d'amélioration de la fonction hépatique
US10039752B2 (en) * 2016-07-21 2018-08-07 Cipla Limited Methazolamide for the treatment of cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783241A (en) * 1957-02-26 S-acylimino-x-substituted-az-i
JP2000080047A (ja) * 1998-06-30 2000-03-21 Takeda Chem Ind Ltd 医 薬
US6946243B2 (en) * 2000-07-20 2005-09-20 Solvay Pharmaceuticals Gmbh Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
CA2419158A1 (fr) * 2000-08-11 2002-02-21 Einar Stefansson Methode de prevention et de traitement des retinopathies
JP2006520335A (ja) * 2003-03-18 2006-09-07 ノバルティス アクチエンゲゼルシャフト 脂肪酸とアミノ酸を含有する組成物
EP2316456B1 (fr) * 2003-04-29 2017-06-14 Orexigen Therapeutics, Inc. Compositions comprenant un antagoniste des opioides et bupropion pour influencer la perte de poids
CA2549025A1 (fr) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Indole-o-glucosides substitues
WO2007114948A2 (fr) * 2006-04-04 2007-10-11 The Brigham And Women's Hospital, Inc. Méthodes et compositions pour inhiber la mort cellulaire
WO2008089521A1 (fr) * 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Sensibilisateurs a l'iinsuline et procédés de traitement
TW201105338A (en) * 2009-07-01 2011-02-16 Kissei Pharmaceutical Medicine derived from a combination of SGLT1-inhibitor and DPP-IV inhibitor
EP3459558B1 (fr) * 2010-06-25 2020-07-29 Aston University Glycoprotéines dotées de propriétés mobilisatrices de lipides et leurs utilisations thérapeutiques
US8937055B2 (en) * 2010-07-15 2015-01-20 Takeda Pharmaceutical Company Limited Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action
WO2013173859A1 (fr) * 2012-05-24 2013-11-28 Verva Pharmaceuticals Ltd Procédé d'amélioration de la fonction hépatique

Also Published As

Publication number Publication date
EP2854806A4 (fr) 2015-11-18
US20180333398A1 (en) 2018-11-22
NZ702666A (en) 2016-08-26
SG11201407786XA (en) 2015-03-30
JP2015520759A (ja) 2015-07-23
RU2014150946A (ru) 2016-07-10
EP2854806A1 (fr) 2015-04-08
ZA201408703B (en) 2018-07-25
AU2013202981B2 (en) 2014-11-13
US20150174108A1 (en) 2015-06-25
AU2013202981A1 (en) 2013-12-12
CA2874512A1 (fr) 2013-11-28
MX2014014316A (es) 2015-07-06
JP6438389B2 (ja) 2018-12-12
CO7160083A2 (es) 2015-01-15
RU2664442C2 (ru) 2018-08-17
BR112014029302A2 (pt) 2017-06-27
CN104582701A (zh) 2015-04-29
CN104582701B (zh) 2018-01-16
WO2013173858A1 (fr) 2013-11-28
KR20150023404A (ko) 2015-03-05

Similar Documents

Publication Publication Date Title
PL2825719T3 (pl) Sposób obsługi odwiertów
GB2506203B (en) Method of interacting with a simulated object
GB201212932D0 (en) Method
PL3560453T3 (pl) Sposób montażu dystalizatora
GB201213636D0 (en) Method
GB201212934D0 (en) Method
GB201210858D0 (en) Method
ZA201503034B (en) Method of weight management
SG11201504454RA (en) A method of vitrification
PL2809816T3 (pl) Sposób ekspresji
GB201218570D0 (en) Method
GB201202198D0 (en) Method
HK1209041A1 (en) A method of weight reduction
SG2013017017A (en) A method of separation
GB201211393D0 (en) Method
GB201215942D0 (en) Method of treatent
GB201217688D0 (en) Method
GB201214029D0 (en) method
GB201210147D0 (en) Method
GB201213858D0 (en) Method
GB201203337D0 (en) Method
GB201201332D0 (en) Method
EP2639418A4 (fr) Procédé de chauffage d'échappement
GB201216100D0 (en) A method of securing two mechanical parts
GB201212279D0 (en) Method of construction